1![INTERNSHIP PROPOSAL Institute and Group: IBS group HIV and persistent human viruses Supervisor: Pascal Poignard Email: Research project title: Human monoclonal antibodies: a new therapeutic strategy INTERNSHIP PROPOSAL Institute and Group: IBS group HIV and persistent human viruses Supervisor: Pascal Poignard Email: Research project title: Human monoclonal antibodies: a new therapeutic strategy](https://www.pdfsearch.io/img/bb4b997712175305ad2c288816e05074.jpg) | Add to Reading ListSource URL: www.labex-gral.frLanguage: English - Date: 2018-02-23 05:16:06
|
---|
2![Visterra Acquires Exclusive Patent License for Monoclonal Antibodies against Dengue Virus from MIT – Expands Company’s Therapeutic Pipeline for Infectious Diseases – Cambridge, MA – December 2, 2013 – Visterra, Visterra Acquires Exclusive Patent License for Monoclonal Antibodies against Dengue Virus from MIT – Expands Company’s Therapeutic Pipeline for Infectious Diseases – Cambridge, MA – December 2, 2013 – Visterra,](https://www.pdfsearch.io/img/e04f3b4efdbf3aa4ce32a0af7663d8fb.jpg) | Add to Reading ListSource URL: www.visterrainc.comLanguage: English - Date: 2017-10-03 19:39:42
|
---|
3![EAP Reimbursement Criteria for Frequently Requested Drugs EAP Reimbursement Criteria for Frequently Requested Drugs](https://www.pdfsearch.io/img/d43800678b09c397af0d769297a7df26.jpg) | Add to Reading ListSource URL: www.health.gov.on.caLanguage: English - Date: 2015-08-17 11:45:03
|
---|
4![24 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO Box 24 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO Box](https://www.pdfsearch.io/img/8cd827cff13922facdce89fcf5252aae.jpg) | Add to Reading ListSource URL: www.nzma.org.nzLanguage: English - Date: 2016-05-25 01:37:50
|
---|
5![12 JulyGeraldine MacGibbon Senior Therapeutic Group Manager PHARMAC PO Box 12 JulyGeraldine MacGibbon Senior Therapeutic Group Manager PHARMAC PO Box](https://www.pdfsearch.io/img/2d2a11fa0b0e3b4e8febe8cc1c1a287b.jpg) | Add to Reading ListSource URL: www.nzma.org.nzLanguage: English - Date: 2016-07-11 21:31:12
|
---|
6![Turning the Repertoire’s Most Potent Antibodies into Superior Therapeutics Immuno-Oncology Targets and Therapeutic Antibodies
Summary • Theraclone deploys a proprietary platform technology that Turning the Repertoire’s Most Potent Antibodies into Superior Therapeutics Immuno-Oncology Targets and Therapeutic Antibodies
Summary • Theraclone deploys a proprietary platform technology that](https://www.pdfsearch.io/img/47199d93816e283e991c42efd0e14073.jpg) | Add to Reading ListSource URL: www.theraclone-sciences.com- Date: 2015-01-08 11:38:14
|
---|
7![For a richer research landscape in Leiden New mouse model, expressing human Fc receptors, to test the efficacy of therapeutic antibodies Key benefits For a richer research landscape in Leiden New mouse model, expressing human Fc receptors, to test the efficacy of therapeutic antibodies Key benefits](https://www.pdfsearch.io/img/3f440d9895ce1dcbcc3aea000204fca1.jpg) | Add to Reading ListSource URL: luris.nlLanguage: English - Date: 2015-04-08 03:57:35
|
---|
8![DrugPlus international - November 2004 • 0 A novel technology for the production of highly active therapeutic proteins by Dr. Hans Baumeister and Dr. Steffen Goletz DrugPlus international - November 2004 • 0 A novel technology for the production of highly active therapeutic proteins by Dr. Hans Baumeister and Dr. Steffen Goletz](https://www.pdfsearch.io/img/ca37d174d42bd9e06b31615351f367fe.jpg) | Add to Reading ListSource URL: www.glycotope.comLanguage: English - Date: 2012-06-20 10:10:40
|
---|
9![sciFLEXARRAYER Application Note NoPeptide microarrays for epitope mapping of antibodies against hTSHR In order to use antibodies as diagnostic markers for the prediction of both prognosis and therapeutic response sciFLEXARRAYER Application Note NoPeptide microarrays for epitope mapping of antibodies against hTSHR In order to use antibodies as diagnostic markers for the prediction of both prognosis and therapeutic response](https://www.pdfsearch.io/img/2cf80f7dad96fc63a4dabade74bcb27c.jpg) | Add to Reading ListSource URL: www.scienion.comLanguage: English - Date: 2014-12-22 07:40:21
|
---|
10![FOR
IMMEDIATE
RELEASE
Theraclone
Sciences’
I-‐STAR™
Technology
Chosen
by
Wellcome
Trust
to
Identify
Therapeutic
Antibodies
Against
Ebol FOR
IMMEDIATE
RELEASE
Theraclone
Sciences’
I-‐STAR™
Technology
Chosen
by
Wellcome
Trust
to
Identify
Therapeutic
Antibodies
Against
Ebol](https://www.pdfsearch.io/img/156f69b50b0d4c9276d63205461aa017.jpg) | Add to Reading ListSource URL: www.theraclone-sciences.comLanguage: English - Date: 2015-04-30 08:07:06
|
---|